GLAXOSMITHKLINE

Lawsuits buy big pharma more time in India, but it's the drug development divisions that will ultimately lose out.

Baxter International admitted to expense violations at a joint venture in China.

Following the investigation of GlaxoSmithKline other foreign pharmaceutical firms could be probed for corruption.

Pharmaceutical giant admits that high-level employees in China "appear to have acted outside of our processes and controls."

The British pharmaceutical firm will detail its response to allegations from Chinese authorities when it gives quarterly results.

China says GlaxoSmithKline acted like a 'Godfather,' criminally routing millions of dollars in bribes to boost its sales in the country.

GlaxoSmithKline said on Monday that it is probing whether its employees bribed local doctors to sell Botox in China.

Chinese police probe the British pharmaceutical giant after its internal investigation finds no evidence of corruption.

After receiving allegations of bribery in its China operations, Glaxo launched an investigation but found no evidence suggesting corruption.

British drug-maker AstraZeneca agreed to buy California's respiratory drug company Pearl Therapeutics for $1.15 billion.

An FDA panel recommended relaxing tough safety restrictions on GlaxoSmithKline's diabetes drug Avandia.

The pharmaceutical industry is grappling with diminishing R&D productivity -- exemplified by a drop in revenue per new drug approval.

LinkedIn Corp, Starbucks Corp, Pan American Silver Corp, Alcatel Lucent, GlaxoSmithKline, Nokia Corp, Deutsche Bank and Weatherford International Ltd. are among the companies whose shares are moving in pre-market trading Friday.

Patent expiries mean annual sales of 15 different categories of heart drugs are set to fall by more than a quarter by 2017, from $83 billion in 2011 to $60 billion, according to consensus analyst forecasts compiled by Thomson Reuters Pharma.

More than 5,000 blood and urine samples will be tested for banned substances at this year's Olympics, more than any previous games.

Human Genome Sciences, Cameco Corp, Barclays Plc, Tata Motors, Cognizant Technology, Banco Santander, Teva Pharmaceutical Industries and Research In Motion are among the companies whose shares are moving in pre-market trading Monday.

The Indian government has taken a major step toward its ambitious vision of achieving Universal Health Coverage (UHC) by initiating a $5.4-billion plan that would allow the government sector doctors to prescribe generic drugs to the patients free of cost.

From city hospitals to tiny rural clinics, India's public doctors will soon be able to prescribe free generic drugs to all comers, vastly expanding access to medicine in a country where public spending on health was just $4.50 per person last year.

GSK targeted the antidepressant Paxil to patients under age 18 when it was approved for adults only, and it pushed the drug Wellbutrin for uses it was not approved for, including weight loss and treatment of sexual dysfunction, according to an investigation led by the U.S. Justice Department.

Bristol-Myers Squibbs' takeover of Amylin follows the trend of pharma companies that are acquiring biotech companies to benefit from growing medical needs, offset patent losses and boost their internal pipeline productivity.

GlaxoSmithKline Plc has agreed to plead guilty to misdemeanor criminal charges and pay $3 billion to settle what government officials said on Monday is the largest case of health care fraud in U.S. history.